Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Methods of use of anti-CD19 antibodies with reduced immunogenicity

US Patent 10072092 · Granted Sep 11, 2018

Estimated economic value: $76,678,000

Assignee

Inventors

View full patent text on Google Patents →